Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-21

Clinical Trial Update: Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA). [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update showing efficacy and safety data for lumiracoxib in knee osteoarthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumiracoxib (Lumiracoxib)

Snippet

Sponsor: Novartis | Conditions: Osteoarthritis, Knee | Phase 3 | Status: COMPLETED